1 / 22

McMahon et al. 2009 Journal of Sexual Medicine 부천성모병원 김효신

Treatment of Premature Ejaculation in the Asia-Pacific Region:Results from a Phase III Double-blind, Parallel-group Study of Dapoxetine. McMahon et al. 2009 Journal of Sexual Medicine 부천성모병원 김효신. Treatment of Premature Ejaculation with dapoxetine. Introduction

hesper
Télécharger la présentation

McMahon et al. 2009 Journal of Sexual Medicine 부천성모병원 김효신

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Treatment of Premature Ejaculation in the Asia-Pacific Region:Results from a Phase III Double-blind, Parallel-group Study of Dapoxetine McMahon et al. 2009 Journal of Sexual Medicine 부천성모병원 김효신

  2. Treatment of Premature Ejaculation with dapoxetine • Introduction Dapoxetine is a short-acting SSRI that was recently approved for the on-demand treatment of premature ejaculation (PE). • Aim To evaluate the efficacy and safety of dapoxetine 30 mg and 60 mg on demand (prn) in men with PE from the Asia-Pacific region.

  3. 중추신경계와 사정

  4. 사정관련 신경전달물질

  5. 사정의 병리학적 원인 Serotonin : 5-hydroxytryptamine, 5-HT, N-methyl-gamma Serotonin Transporter: 5-HTT 중추신경계적 원인 세로토닌 시스템의 이상 > 5-HT2c receptor 기능저하 > 5-HT1A receptor 기능과잉 말초적 원인 음경의 감각 과민 사정반사신경의 과도한 흥분

  6. 사정조절의 핵심: 세로토닌

  7. 사정조절의 핵심: 세로토닌 Selective serotonin reuptake inhibitors or serotonin-specific reuptake inhibitor: class of compounds typically used as antidepressants in the treatment of depression,anxiety disorders, and some personality disorders. They are also typically effective and used in treating premature ejaculation problems as well as some cases of insomnia. SSRIs increase the extracellular level of the neurotransmitter serotonin by inhibiting its reuptake into the presynaptic cell, increasing the level of serotonin available to bind to the postsynaptic receptor. citalopram (Celexa, Cipramil, Cipram, Dalsan, Recital, Emocal, Sepram, Seropram, Citox) dapoxetine (no trade name yet; not yet approved by the FDA) escitalopram (Lexapro, Cipralex, Esertia) fluoxetine (Prozac, Fontex, Seromex, Seronil, Sarafem, Ladose, Fluctin (EUR), Fluox (NZ), Depress (UZB), Lovan (AUS)) fluvoxamine (Luvox, Fevarin, Faverin, Dumyrox, Favoxil, Movox) paroxetine (Paxil, Seroxat, Sereupin, Aropax, Deroxat, Rexetin, Xetanor, Paroxat) sertraline (Zoloft, Lustral, Serlain) zimelidine (Zelmid, Normud)

  8. 약물동력학 Peak plasma concentrations (Cmax) 은 복용후 1.3시간후 도달합니다(Tmax). initial half-life는 90 minutes이며, 24시간 후 peak concentration 대비 약 4%미만으로 농도가 떨어집니다. 따라서 반복투여에 의한 체내 축적이 최소화되었습니다. 음식, 알코올, PDE5I와 약물상호작용이 적음

  9. Methods • Subjects • 18 years or older; monogamous, heterosexual relationship > 6 months - Diagnostic and Statistical Manual of Mental Disorders 4th edit. text revision, criteria for PE for at least 6 months; • intravaginal ejaculatory latency time (IELT) of 2 minutes or less in at least 75% of sexual intercourse episodes. • Study design - Randomized, double-blind, parallel-group, placebo-controlled trial - 52 centers in Australia, China, Korea, Taiwan, Malaysia, Philippines, Thailand, Singapore, and HongKong 12-week double-blind treatment taking prn (1-3 hrs before intercourse) Post-study telephone contact placebo Pre-randomization Dapoxetine 30mg 2wks after discontinuation of study drug Screening visit Dapoxetine 60mg

  10. Main Outcome Measures Efficacy assessments • Stopwatch-measured Average IELT • Patient-reported outcome • the Premature Ejaculation Profile (PEP) - Perceived control over ejaculation - Satisfaction with sexual intercourse - Ejaculation-related personal distress - Interpersonal difficulty • Clinical Global Impression (CGI) of change in PE • Composite PRO definition of clinical benefit Safety assessments • treatment-emergent adverse events (TEAEs)

  11. Results_ subject disposition Of the 1,067 subjects randomized, 858 completed the study.

  12. Results • 858/1067 pts. completed the study - 295 (83%), 284 (80%), and 279 (78%) • Withdrawal: personal reasons, insufficient response, etc • most common TEAEs: nausea, dizziness, somnolence, headache, vomiting, diarrhea, and nasopharyngitis • baseline, mean Average IELT : 1.0±0.47,1.1±0.45, 1.1±0.48 minutes • <0.5min 14%, 0.5~1min 45%, 1~2min 55%

  13. Results • Increased Mean Average IELT • No differences between dapoxetine groups at any time point. • Increased Geometric Mean Average IELT(Standard error) • All PEP measures and the CGI of change were significantly improved with dapoxetine vs. placebo at study endpoint (P 0.005 for all).

  14. Results_ IELT, intravaginal ejaculatory latency time

  15. Results_ Control over ejaculation during sexual intercourse (P < 0.001) 33.5 33.5 18.7 1.6 0.6 0.9

  16. Results_ Satisfaction with sexual intercourse (P < 0.001) 41.3 40.9 29.0 4.3 4.3 3.9

  17. Results_ ejaculation-related interpersonal difficulty of subjects (P < 0.001) 76.4 73.5 74.3 36.4 25.2 19.6

  18. Results_ ejaculation-related interpersonal difficulty ofpartners (P ≤ 0.005) 51.9 50.3 48.8 27.3 17.9 13.4

  19. Safety_ TEAEs (Treatment-emergent adverse events) The most common TEAEs with dapoxetine; nausea, dizziness, somnolence, headache, vomiting, diarrhea, and nasopharyngitis; TEAEs ratio leading discontinuation

  20. 요약 IELT를 3-4 배 증가 초회 복용부터 효과 사정에 대한 control을 향상 성행위에 대한 만족도를 향상 파트너의 성생활 만족도를 향상 전반적으로 내약성이 우수

  21. 경청해 주셔서 감사합니다.

More Related